Rhumbline Advisers Ideaya Biosciences, Inc. Transaction History

Rhumbline Advisers

$113 Billion
Q2 2025

A detailed history of Rhumbline Advisers transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 131,149 shares of IDYA stock, worth $3.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

131,149

Previous 124,437 5.39%

Holding current value

$3.52 Million

Previous $2.04 Million 35.23%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$14.5 - $22.63 $97,324 - $151,892	6,712 Added 5.39%	131,149 $2.76 Million
Q1 2025 Apr 08, 2025	BUY	$16.38 - $26.0 $178,148 - $282,776	10,876 Added 9.58%	124,437 $2.12 Million
Q4 2024 May 29, 2025	SELL	$24.79 - $31.98 $269,616 - $347,814	-10,876 Reduced 8.74%	113,561 $2.92 Million
Q4 2024 Jan 30, 2025	BUY	$24.79 - $31.98 $14,502 - $18,708	585 Added 0.52%	113,561 $2.92 Million
Q3 2024 Nov 12, 2024	BUY	$30.37 - $43.05 $218,026 - $309,055	7,179 Added 6.79%	112,976 $3.58 Million
Q2 2024 Aug 01, 2024	BUY	$34.37 - $43.46 $322,631 - $407,959	9,387 Added 9.74%	105,797 $3.71 Million
Q1 2024 May 09, 2024	BUY	$34.2 - $47.13 $357,184 - $492,225	10,444 Added 12.15%	96,410 $4.23 Million
Q4 2023 Feb 08, 2024	BUY	$24.59 - $35.83 $176,359 - $256,972	7,172 Added 9.1%	85,966 $3.06 Million
Q3 2023 Nov 09, 2023	BUY	$21.07 - $29.77 $38,178 - $53,943	1,812 Added 2.35%	78,794 $2.13 Million
Q2 2023 Aug 08, 2023	BUY	$13.33 - $25.53 $103,587 - $198,393	7,771 Added 11.23%	76,982 $1.81 Million
Q1 2023 May 11, 2023	BUY	$13.49 - $18.72 $69,837 - $96,913	5,177 Added 8.08%	69,211 $950,000
Q4 2022 Feb 14, 2023	BUY	$14.47 - $18.17 $149,851 - $188,168	10,356 Added 19.29%	64,034 $1.16 Million
Q3 2022 Nov 10, 2022	BUY	$9.24 - $15.79 $33,920 - $57,965	3,671 Added 7.34%	53,678 $801,000
Q2 2022 Aug 11, 2022	BUY	$8.28 - $13.88 $83,007 - $139,147	10,025 Added 25.07%	50,007 $690,000
Q1 2022 May 12, 2022	BUY	$11.18 - $24.02 $20,515 - $44,076	1,835 Added 4.81%	39,982 $447,000
Q4 2021 Feb 10, 2022	BUY	$20.95 - $26.88 $60,482 - $77,602	2,887 Added 8.19%	38,147 $902,000
Q3 2021 Nov 12, 2021	BUY	$17.26 - $27.08 $101,644 - $159,474	5,889 Added 20.05%	35,260 $899,000
Q2 2021 Aug 05, 2021	BUY	$17.76 - $24.83 $191,150 - $267,245	10,763 Added 57.84%	29,371 $616,000
Q1 2021 May 06, 2021	BUY	$13.48 - $23.77 $14,679 - $25,885	1,089 Added 6.22%	18,608 $437,000
Q4 2020 Feb 10, 2021	BUY	$12.17 - $17.52 $46,842 - $67,434	3,849 Added 28.16%	17,519 $245,000
Q3 2020 Nov 12, 2020	BUY	$11.22 - $14.46 $3,635 - $4,685	324 Added 2.43%	13,670 $172,000
Q2 2020 Aug 13, 2020	BUY	$3.59 - $18.57 $47,912 - $247,835	13,346 New	13,346 $190,000

Others Institutions Holding IDYA

# of Institutions

219

Shares Held

83.4M

Call Options Held

28.7K

Put Options Held

132K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.29B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Ideaya Biosciences, Inc. Transaction History